Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.14-3.38%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 195.43% | 32.44% | 140.08% | -226.75% | 25.80% |
| Total Depreciation and Amortization | -201.03% | -- | -- | 301.02% | -201.16% |
| Total Amortization of Deferred Charges | -201.03% | -- | -- | 299.51% | -201.16% |
| Total Other Non-Cash Items | -120.56% | -404.99% | -95.81% | 283.95% | -254.90% |
| Change in Net Operating Assets | 201.03% | -- | -- | -129.98% | 201.16% |
| Cash from Operations | 58.69% | 7.07% | -62.23% | 28.47% | 1,125.93% |
| Capital Expenditure | -39.37% | -10.30% | 39.40% | -3.06% | 15.48% |
| Sale of Property, Plant, and Equipment | -93.72% | 5,610.42% | -98.39% | 3,496.39% | 153.21% |
| Cash Acquisitions | -- | 100.00% | 99.35% | -1,277.96% | -772.34% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.13% | 224.92% | -142.86% | 239.40% | 77.07% |
| Cash from Investing | -35.71% | 207.61% | -166.12% | 188.92% | 75.26% |
| Total Debt Issued | -92.26% | -18.17% | 3.62% | -59.65% | 16.27% |
| Total Debt Repaid | 8.51% | -203.05% | 84.03% | -62.46% | -69.97% |
| Issuance of Common Stock | -- | -- | -12.10% | -75.03% | 759.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 71.23% | -808.67% | 19.64% | 93.92% | -1,525.70% |
| Other Financing Activities | -201.18% | 207.84% | -242.52% | 182.99% | -602.12% |
| Cash from Financing | -19.85% | -600.28% | 92.82% | -197.68% | -337.38% |
| Foreign Exchange rate Adjustments | -222.78% | 90.69% | -66.84% | 163.49% | -458.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -145.55% | 136.14% | -738.15% | 107.17% | 71.47% |